MedPath

Water Immersion and Polyp Detection: A Randomized Controlled Trial

Not Applicable
Completed
Conditions
Adenoma
Colonic Neoplasms
Interventions
Procedure: CO2 Insufflation First
Procedure: Water Infusion first
Registration Number
NCT03231917
Lead Sponsor
White River Junction Veterans Affairs Medical Center
Brief Summary

We plan to conduct a randomized trial of tandem colonoscopies comparing water infusion and air insufflation for inspection of mucosa on withdrawal. In one randomized group, water infusion will be employed as the first method for mucosal inspection while in a second group, CO2 insufflation will be used first. This study will be different than usual care since the participants will receive two successive or tandem colonoscopies versus one

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
121
Inclusion Criteria
  • all adults 50 years or older who present for colonoscopy at White River Junction VAMC and Indiana University
Exclusion Criteria
  • includes co-morbid status of ASA III or higher, Inflammatory Bowel Disease (IBD), surgical resection of the large bowel, as well as the use of anticoagulants. Finally, potential subjects who do not report a clear effluent in the most recent bowel movement will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CO2 Insufflation FirstCO2 Insufflation FirstIn this group patients will receive a colonoscopy with CO2 insufflation for mucosal inspection and then receive a colonoscopy with water infusion.
Water Infusion firstWater Infusion firstIn this group patients will receive a colonoscopy with water infusion for mucosal inspection and then receive a colonoscopy with CO2 insufflation.
Primary Outcome Measures
NameTimeMethod
Adenoma Miss RateThrough procedure, an average of 1 hr

Adenoma-level miss rates will be calculated as the number of additional adenomas detected during the second examination divided by the total number of adenomas detected during both examinations

Secondary Outcome Measures
NameTimeMethod
Patient-level Miss Rate1 hour or the duration of the procedure

Patient-level miss rates will be calculated as the number of patients with one or more adenomas detected during the second examination, divided by the total number of patients with at least one adenoma in either examination

Adenoma < 6mm Detection Rate1 hour or the duration of the procedure

Adenoma-level miss rates will be calculated as the number of additional adenomas \< 6 mm detected during the second examination divided by the total number of adenomas\< 6 mm detected during both examinations.

Trial Locations

Locations (2)

Indiana University Hospital

🇺🇸

Indianapolis, Indiana, United States

University of Connecticut Health Center

🇺🇸

Farmington, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath